NCT03211403View on ClinicalTrials.gov

Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 4, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

February 15, 2018

Conditions
GoutHyperuricemia
Interventions
DRUG

SHR4640

SHR4640 or placebo once daily for a week

Trial Locations (1)

2000

Atridia Pty Limited, Sydney

All Listed Sponsors
lead

Atridia Pty Ltd.

INDUSTRY

NCT03211403 - Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level | Biotech Hunter | Biotech Hunter